Search Within

Harry W Herr

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (18)
  3. Conference Paper (3)
  4. Book Section (1)
  5. Book Whole (1)
  6. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (79)
  2. Surgery (79)
  3. Urology (79)
  4. Department of Medicine (35)
  5. Genitourinary Oncology Service (35)
  6. Solid Tumor Oncology Division (35)

More Groups

People
  1. Victor Reuter (58)
  2. Guido Dalbagni (43)
  3. Bernard Bochner (29)
  4. Sherri Donat (27)
  5. Dean Bajorin (25)
  6. Hikmat Al-Ahmadie (25)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Urology (20)
  2. Journal of Clinical Oncology (13)
  3. BJU International (4)
  4. Laboratory Investigation (4)
  5. Urology (4)
  6. British Journal of Urology (3)

More Publications

Publishers
  1. Elsevier Science, Inc. (27)
  2. American Society of Clinical Oncology (15)
  3. Wiley Blackwell (9)
  4. Elsevier Inc. (5)
  5. Nature Publishing Group (5)
  6. American Association for Cancer Research (4)

More Publishers

Results (79)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
    Journal Article

    Isharwal, S.; Huang, H.; Nanjangud, G.; Audenet, F.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Lee, B. H.; Iyer, G.; more...
    Human Pathology (2018)

    Fulltext@MSK | Save
  • Urothelial neoplasms in pediatric and young adult patients: A large single-center series
    Journal Article

    Saltsman, J. A.; Malek, M. M.; Reuter, V. E.; Hammond, W. J.; Danzer, E.; Herr, H. W.; LaQuaglia, M. P.
    Journal of Pediatric Surgery (2018)

    Fulltext@MSK | Save
  • Differences in somatic DNA damage repair (DDR) gene alterations between primary and secondary muscle invasive bladder cancer (MIBC)
    Meeting Abstract

    Pietzak, E. J.; Bagrodia, A.; Li, Q.; Al-Ahmadie, H.; Herr, H. W.; Funt, S.; Barron, D.; Zehir, A.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
    Journal Article

    Kim, P. H.; Sukhu, R.; Cordon, B. H.; Sfakianos, J. P.; Sjoberg, D. D.; Hakimi, A. A.; Dalbagni, G.; Lin, O.; Herr, H. W.
    BJU International (2014)

    Fulltext@MSK | Save